Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating) saw strong trading volume on Tuesday . 22,955 shares traded hands during mid-day trading, a decline of 90% from the previous session's volume of 223,037 shares.The stock last traded at $13.87 and had previously closed at $14.16.
Cardiovascular Systems Stock Up 3.3 %
The company has a debt-to-equity ratio of 0.08, a current ratio of 6.05 and a quick ratio of 5.19. The firm has a fifty day moving average of $15.14 and a 200 day moving average of $17.10.
Get Cardiovascular Systems alerts:Institutional Investors Weigh In On Cardiovascular Systems
Several hedge funds and other institutional investors have recently made changes to their positions in CSII. Assenagon Asset Management S.A. increased its holdings in shares of Cardiovascular Systems by 116.3% in the second quarter. Assenagon Asset Management S.A. now owns 859,065 shares of the medical device company's stock valued at $12,336,000 after purchasing an additional 461,931 shares during the last quarter. Cubist Systematic Strategies LLC increased its holdings in shares of Cardiovascular Systems by 579.7% in the second quarter. Cubist Systematic Strategies LLC now owns 318,511 shares of the medical device company's stock valued at $4,574,000 after purchasing an additional 271,649 shares during the last quarter. Grandeur Peak Global Advisors LLC increased its holdings in shares of Cardiovascular Systems by 36.2% in the fourth quarter. Grandeur Peak Global Advisors LLC now owns 564,582 shares of the medical device company's stock valued at $10,603,000 after purchasing an additional 150,103 shares during the last quarter. BNP Paribas Arbitrage SA increased its holdings in shares of Cardiovascular Systems by 344.6% in the fourth quarter. BNP Paribas Arbitrage SA now owns 171,228 shares of the medical device company's stock valued at $3,216,000 after purchasing an additional 132,716 shares during the last quarter. Finally, Walleye Capital LLC increased its holdings in shares of Cardiovascular Systems by 185.5% in the fourth quarter. Walleye Capital LLC now owns 200,015 shares of the medical device company's stock valued at $3,756,000 after purchasing an additional 129,967 shares during the last quarter. Institutional investors and hedge funds own 91.72% of the company's stock.
Cardiovascular Systems Company Profile
(Get Rating)Cardiovascular Systems, Inc, a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.
Read More
- Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
- Murphy USA Outperforming Other Mid-caps, But Is It A Buy Now?
- Has 3M Reached the Point of Being so Bad It's Good?
- Is This Medical Gear Maker Ready To Continue Its Rally?
- The Five (5) Hottest Stocks To Watch Ahead Of Q3 Earnings
- Has Take-Two Interactive Devolved into a One-Trick Pony?
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.